veloxsol 5 mg schmelztabletten
intas third party sales 2005 s.l. (8184005) - solifenacinsuccinat - schmelztablette - 5 mg - teil 1 - schmelztablette; solifenacinsuccinat (25892) 5 milligramm
veloxsol 10 mg schmelztabletten
intas third party sales 2005 s.l. (8184005) - solifenacinsuccinat - schmelztablette - 10 mg - teil 1 - schmelztablette; solifenacinsuccinat (25892) 10 milligramm
sitagliptin / metformin hydrochloride accord
accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, typ 2 - drogen bei diabetes verwendet - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , dreifach-kombinationstherapie) als ergänzung zu diät und bewegung bei patienten, die unzureichend kontrolliert auf ihren maximalen tolerierten dosis von metformin und sulphonylurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.
sitagliptin genericon 100 mg filmtabletten
genericon pharma gesellschaft m.b.h. - sitagliptin hydrochlorid monohydrat -
sitagliptin genericon 25 mg filmtabletten
genericon pharma gesellschaft m.b.h. - sitagliptin hydrochlorid monohydrat -
sitagliptin genericon 50 mg filmtabletten
genericon pharma gesellschaft m.b.h. - sitagliptin hydrochlorid monohydrat -
sitagliptin +pharma 100 mg filmtabletten
+pharma arzneimittel gmbh - sitagliptin hydrochlorid monohydrat -
sitagliptin +pharma 25 mg filmtabletten
+pharma arzneimittel gmbh - sitagliptin hydrochlorid monohydrat -
sitagliptin +pharma 50 mg filmtabletten
+pharma arzneimittel gmbh - sitagliptin hydrochlorid monohydrat -
sitagliptin-metformin-mepha 50/500 mg filmtabletten
mepha pharma ag - metformini hydrochloridum, sitagliptinum - filmtabletten - metformini hydrochloridum 500 mg, sitagliptinum 50 mg ut sitagliptini hydrochloridum monohydricum, cellulosum microcristallinum, povidonum k 29-32, natrii laurilsulfas, natrii stearylis fumaras, Überzug: poly(alcohol vinylicus), e 171, macrogola, talcum, e 172 (flavum), e 172 (rubrum), pro compresso obducto corresp. natrium 1.025 mg. - diabetes typ 2 - synthetika